Welcome to CDC Stacks | Rapidly Fatal Hemorrhagic Pneumonia and Group A Streptococcus Serotype M1 - 22256 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Rapidly Fatal Hemorrhagic Pneumonia and Group A Streptococcus Serotype M1
  • Published Date:
    Jan 2014
  • Source:
    Emerg Infect Dis. 20(1):98-101.
Filetype[PDF - 410.98 KB]


Details:
No Related Documents.
You May Also Like:
  1. Rapidly Fatal Hemorrhagic Pneumonia and Group A Streptococcus Serotype M1
    Personal Author:
    Santagati, Maria; Spanu, Teresa; Scillato, Marina; Santangelo, Rosaria; Cavallaro, Fabio; Arena, Vincenzo; Castiglione, Giacomo; Falcone, Marco; Venditti, Mario; Stefani, Stefania;
    Published:
    Jan 2013
    Source:
    Emerg Infect Dis. 20(1):98-101.
    Description:
    We report 3 cases of fulminant hemorrhagic pneumonia in previously health patients. Sudden-onset hemoptysis and dyspnea developed; all 3 patients and died <12 h later of massive pulmonary bleeding, despite aggressive supportive care. Postmortem analy...
    File Type:
    Filetype[PDF - 410.98 KB]
  2. Rapid molecular genetic subtyping of serotype M1 group A Streptococcus strains.
    Personal Author:
    Hoe, N.; Nakashima, K.; Grigsby, D.; Pan, X.; Dou, S. J.; Naidich, S.; Garcia, M.; Kahn, E.; Bergmire-Sweat, D.; Musser, J. M.;
    Published:
    1999 Mar-Apr
    Source:
    Emerg Infect Dis. 5(2):254-263.
    Description:
    Serotype M1 group A Streptococcus, the most common cause of invasive disease in many case series, generally have resisted extensive molecular subtyping by standard techniques (e.g., multilocus enzyme electrophoresis, pulsed-field gel electrophoresis)...
    File Type:
    Filetype[PDF - 258.00 KB]
  3. Population Structure and Antimicrobial Resistance of Invasive Serotype IV Group B Streptococcus, Toronto, Ontario, Canada
    Personal Author:
    Teatero, Sarah; McGeer, Allison; Li, Aimin; Gomes, Janice; Seah, Christine; Demczuk, Walter; Martin, Irene; Wasserscheid, Jessica; Dewar, Ken; Melano, Roberto G.; Fittipaldi, Nahuel;
    Published:
    Apr 2015
    Source:
    Emerg Infect Dis. 21(4):585-591.
    Description:
    We recently showed that 37/600 (6.2%) invasive infections with group B Streptococcus (GBS) in Toronto, Ontario, Canada, were caused by serotype IV strains. We report a relatively high level of genetic diversity in 37 invasive strains of this emerging...
    File Type:
    Filetype[PDF - 1.21 MB]
  4. Serotype IV and Invasive Group B Streptococcus Disease in Neonates, Minnesota, USA, 2000–20101
    Personal Author:
    Ferrieri, Patricia; Lynfield, Ruth; Creti, Roberta; Flores, Aurea E.;
    Published:
    Apr 2013
    Source:
    Emerg Infect Dis. 19(4):551-558.
    Description:
    Group B Streptococcus (GBS) is a major cause of invasive disease in neonates in the United States. Surveillance of invasive GBS disease in Minnesota, USA, during 2000-2010 yielded 449 isolates from 449 infants; 257 had early-onset (EO) disease (by ag...
    File Type:
    Filetype[PDF - 532.58 KB]
  5. Attributable healthcare utilization and cost of pneumonia due to drug-resistant streptococcus pneumonia: a cost analysis
    Personal Author:
    Reynolds, Courtney A; Finkelstein, Jonathan A; Ray, G Thomas; Moore, Matthew R; Huang, Susan S;
    Published:
    May 21 2014
    Source:
    Antimicrob Resist Infect Control. 2014; 3:16.
    Description:
    Background : The burden of disease due to S. pneumoniae (pneumococcus), particularly pneumonia, remains high despite the widespread use of vaccines. Drug resistant strains complicate clinical treatment and may increase costs. We estimated the annual ...
    File Type:
    Filetype[PDF - 790.72 KB]